NASDAQ:BSGM - Nasdaq - US09073N3008 - Common Stock - Currency: USD
0.925
+0.1 (+12.13%)
The current stock price of BSGM is 0.925 USD. In the past month the price decreased by -14.35%. In the past year, price decreased by -80.1%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
SYK | STRYKER CORP | 31.4 | 145.92B | ||
MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
DXCM | DEXCOM INC | 53.81 | 34.68B | ||
RMD | RESMED INC | 26.21 | 34.03B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
BioSig Technologies, Inc. is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiographic and intra-cardiac signals. The company is headquartered in Westport, Connecticut and currently employs 4 full-time employees. The company went IPO on 2014-09-22. The Company’s product, the PURE EP Platform, a non-invasive class II device, provides real-time signal visualization allowing physicians to perform highly targeted cardiac ablation procedures. Integrating with existing systems in the EP lab, PURE EP is designed to pinpoint even the complex signals to maximize procedural success and efficiency. The PURE EP System is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures, such as environmental lab noise from other equipment, signal saturation, slow signal recovery, and inaccurate display of fractionated potentials. PURE EP is a signal processing platform that combines advanced hardware and software to address known challenges associated to signal acquisition, to enable electrophysiologists to see more signals and analyze them in real-time.
BIOSIG TECHNOLOGIES INC
55 Greens Farms Road
Westport CONNECTICUT 06880 US
CEO: Kenneth L. Londoner
Employees: 4
Company Website: https://www.biosig.com/
Phone: 12034095444
The current stock price of BSGM is 0.925 USD. The price increased by 12.13% in the last trading session.
The exchange symbol of BIOSIG TECHNOLOGIES INC is BSGM and it is listed on the Nasdaq exchange.
BSGM stock is listed on the Nasdaq exchange.
7 analysts have analysed BSGM and the average price target is 2.81 USD. This implies a price increase of 203.24% is expected in the next year compared to the current price of 0.925. Check the BIOSIG TECHNOLOGIES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
BIOSIG TECHNOLOGIES INC (BSGM) has a market capitalization of 15.94M USD. This makes BSGM a Nano Cap stock.
BIOSIG TECHNOLOGIES INC (BSGM) currently has 4 employees.
BIOSIG TECHNOLOGIES INC (BSGM) has a support level at 0.91 and a resistance level at 1. Check the full technical report for a detailed analysis of BSGM support and resistance levels.
The Revenue of BIOSIG TECHNOLOGIES INC (BSGM) is expected to decline by -100% in the next year. Check the estimates tab for more information on the BSGM EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BSGM does not pay a dividend.
BIOSIG TECHNOLOGIES INC (BSGM) will report earnings on 2025-04-14, after the market close.
BIOSIG TECHNOLOGIES INC (BSGM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.6).
The outstanding short interest for BIOSIG TECHNOLOGIES INC (BSGM) is 3.15% of its float. Check the ownership tab for more information on the BSGM short interest.
ChartMill assigns a fundamental rating of 1 / 10 to BSGM. BSGM has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months BSGM reported a non-GAAP Earnings per Share(EPS) of -1.6. The EPS increased by 66.81% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -1589.24% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 83% to BSGM. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 78.73% and a revenue growth -100% for BSGM